Pathways of dysregulation in renal cell carcinoma: rational approaches to development of novel treatment.

Clinical genitourinary cancer

Volumn 5 Suppl 1, Issue , 2006, Pages S7-

  Khasawneh, Mohamad K ^a   Bukowski, Ronald M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 34047215912     PISSN: 15587673     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2006.s.002     Document Type: Article

References (115)